X-group (possible homology)

3110 STT3/PglB/AglB core domain

Ligands and drugs

418
Member domains
24
with ligand contacts (≤ 4 Å)
5.7% of members
29
with DrugDomain annotations
6.9% of members
8
with a DrugBank compound
1.9% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

9
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous non-metal compounds31.91.57×not tested
Organoheterocyclic compounds21.41.47×not tested
Homogeneous metal compounds64.41.38×not tested
Organic oxygen compounds21.81.13×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine5

Most frequently bound compounds

PDB ligandNameDomains in contact
CAmetalCALCIUM ION13
CLCHLORIDE ION7
3232-[3,6-bis(dimethylamino)xanthen-9-yl]-5-methanoyl-benzoate2
MNmetalMANGANESE (II) ION2
7E8(2R)-2,3-DIHYDROXYPROPYL (7Z)-TETRADEC-7-ENOATE1
9UB[(2~{S},3~{R},4~{R},5~{S},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]methyl-[oxidanyl-[(2~{Z},6~{Z},10~{Z})-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]phosphoryl]oxy-phosphinic acid1
FFK[(2~{R},3~{R},4~{R},5~{S},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl] [oxidanyl-[(2~{Z},6~{Z},10~{Z})-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]phosphoryl] hydrogen phosphate1
MGmetalMAGNESIUM ION1
NAG2-acetamido-2-deoxy-beta-D-glucopyranose1
ZXT5-(dimethylsulfamoyl)-~{N}-(5-methyl-1,3-thiazol-2-yl)-2-pyrrolidin-1-yl-benzamide1